Clinical value of molecular MRD monitoring by next-generation sequencing in patients with IDH2 mutated AML
暂无分享,去创建一个
U. Amstutz | E. Shumilov | T. Pabst | U. Novak | J. Flach | U. Bacher | R. Joncourt | Gertrud Wiedemann | N. Porret | B. Jeker | Eva Gfeller